Marina Biotech Announces the Appointment of Dr. Vuong Trieu as Executive Chairman
July 05, 2017 08:30 ET | Marina Biotech, Inc.
CITY OF INDUSTRY, CA--(Marketwired - Jul 5, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
Marina Biotech Acquires Prestalia(R), a U.S. FDA Approved Drug for Patients Whose Blood Pressure Is Not Adequately Controlled by Monotherapy
June 06, 2017 08:30 ET | Marina Biotech, Inc.
CITY OF INDUSTRY, CA--(Marketwired - Jun 6, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
Marina Biotech Provides Business Update
April 05, 2017 08:45 ET | Marina Biotech, Inc.
CITY OF INDUSTRY, CA--(Marketwired - Apr 5, 2017) -   Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative...
Marina Biotech Signs Definitive Agreement with Windlas Healthcare to Manufacture IT-102 FDC Bi-Layer Tablet
April 03, 2017 09:00 ET | Marina Biotech, Inc.
CITY OF INDUSTRY, CA--(Marketwired - Apr 3, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
Marina Biotech to Present Data on Vascular Resistance and Cancer at the Endocrine Society Annual Meeting on April 1
March 24, 2017 09:10 ET | Marina Biotech, Inc.
CITY OF INDUSTRY, CA--(Marketwired - Mar 24, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...